肝癌介入术后随访的影像学比较  

After liver cancer involves the technique, makes a follow--up visit phantom study comparison

作　　者：吴小蓉[1] 唐国桂 

机构地区：[1]江苏省东台市中医院,东台224200

出　　处：《按摩与康复医学》2010年第12期15-16,共2页Chinese Manipulation and Rehabilitation Medicine

摘　　要：经导管肝动脉化疗栓塞术（TACE）治疗肝细胞癌（HCC）已有30年历史，1979年开始用碘化油栓塞治疗肝癌并逐渐应用于临床，现已成为HCC非手术治疗的有效和首选方法。其基本原理：肝细胞癌的血供主要来自肝动脉，尤其是有包膜的肝细胞癌，经导管自肝动脉注入化疗药物的杀伤作用与药物的浓度及与癌细胞的接触时间成正比，肝动脉灌注化疗可明显提高抗癌药物的杀伤作用，减少副反应。将提供肿瘤营养的肝动脉支栓塞，使肿瘤缺血坏死。灌注化疗与碘油栓塞并用可增加化疗药物与癌肿的接触时间，最终达到肿瘤缩小，控制肿瘤生长的目的。Treats the hepatocellular carcinoma after the drive pipe hepatic artery chemotherapy embolism technique （HCC） to have 30 year history, in 1979 started with the iodized oil embolism to treat liver cancer and to apply gradually in clinical, already became the HCC non--surgery to treat effective and the first choice method. Its basic principle： Hepatocellular carcinoma＇s blood for mainly comes from the hepatic artery, particularly has the involucrum hepatocellular carcinoma, pours into the chemotherapy medicine after the drive pipe from the hepatic artery the damaging effect and the medicine density and is proportional with cancer cell＇s contact duration, the hepatic artery irrigation chemotherapy may enhance the antieancer treatment medicine obviously the damaging effect, reduces the side reaction. Will provide the tumor nutrition a hepatic artery embolism, causes the tumor ischemia necrosis. The irrigation chemotherapy and iodine oil embolism and with may increase the chemotherapy medicine and cancer＇s contact duration, achieves the tumor to reduce finally, the control tumor grows goal.

关 键 词：肝细胞癌 经导管肝动脉化疗栓塞术后 随访 

分 类 号：R735.7[医药卫生—肿瘤]